IMC Chicago’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.11M Sell
186,100
-60,100
-24% -$452K ﹤0.01% 3163
2025
Q4
$1.77M Buy
246,200
+19,400
+9% +$153K ﹤0.01% 2533
2025
Q3
$2.42M Buy
226,800
+93,900
+71% +$922K ﹤0.01% 2089
2025
Q2
$1.29M Buy
132,900
+69,400
+109% +$716K ﹤0.01% 2308
2025
Q1
$946K Buy
63,500
+20,000
+46% +$308K ﹤0.01% 2310
2024
Q4
$649K Buy
43,500
+2,400
+6% +$39.1K ﹤0.01% 2610
2024
Q3
$786K Buy
41,100
+17,900
+77% +$371K ﹤0.01% 2166
2024
Q2
$480K Sell
23,200
-4,200
-15% -$83.5K ﹤0.01% 2301
2024
Q1
$515K Buy
+27,400
New +$470K ﹤0.01% 2030

Other funds holding OGN

IMC Chicago's OGN Position: Q1 2026 in Review

IMC Chicago opened a new position in Organon & Co (OGN) in Q1 2026: 47,531 shares worth $285K. The stake represents ﹤0.01% of the portfolio and ranks #4652 among its holdings. This is a return to the name: IMC Chicago previously reported a position in OGN as recently as Q1 2025.

IMC Chicago first reported a position in OGN in Q1 2024 and has held it in 4 quarters since. The position peaked at $1.3M in Q4 2024. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • IMC Chicago held 47,531 shares of Organon & Co worth $285K as of Q1 2026.
  • Organon & Co was a new IMC Chicago position in Q1 2026.
  • Organon & Co made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #4652 holding.
  • IMC Chicago first reported a position in Organon & Co in Q1 2024 and has held it in 4 quarters since.
  • IMC Chicago's Organon & Co position peaked at $1.3M in Q4 2024.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.